Skip to content

IAS: Remaining on 3TC despite resistance leads to better immunological and clinical outcomes

IAS: The New York Patient - source found but mysteries remain

IDUs acquire resistance at same rate as non-IDUs

Proof-of-concept study shows benefits of Kaletra / efavirenz combination

Viral load ‘blips’ on NNRTIs linked to low-level viral replication but not treatment failure

XIV International HIV Drug Resistance Workshop: Epidemiology

XIV International HIV Drug Resistance Workshop: Entry inhibitors

Key take-home messages from the XIV International HIV Drug Resistance Workshop

XIV International HIV Drug Resistance Workshop: Clinical response